isosorbide dinitrate has been researched along with Hyperpotassemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for isosorbide dinitrate and Hyperpotassemia
| Article | Year |
|---|---|
Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Cardiotonic Agents; Cohort Studies; Contraindications; Female; Hospitalization; Humans; Hydralazine; Hyperkalemia; Isosorbide Dinitrate; Male; Medicare; Middle Aged; Multivariate Analysis; Patient Discharge; Peer Review, Health Care; Professional Review Organizations; Renal Insufficiency; Retrospective Studies; Stroke Volume; United States; United States Agency for Healthcare Research and Quality; Vasodilator Agents | 1997 |